Related Experiment Videos
Childhood onset inclusion body myositis mimicking limb-girdle muscular dystrophy
J E Riggs1, S S Schochet, L Gutmann
1Department of Neurology, West Virginia University School of Medicine, Morgantown 26506.
Journal of Child Neurology
|October 1, 1989
Abstract:
Inclusion body myositis was initially recognized in patients with "steroid-resistant polymyositis" and subsequently in patients with other immune-mediated disorders. The finding of inclusion body myositis in a patient diagnosed for 30 years as having limb-girdle muscular dystrophy suggests yet another patient pool that may harbor this entity.
Insights
Inclusion body myositis can be misdiagnosed, even in patients with long-term limb-girdle muscular dystrophy diagnoses. This highlights the need for broader diagnostic considerations in myositis cases.
Area of Science:
- Neurology
- Immunology
- Genetics
Background:
- Inclusion body myositis (IBM) was first identified in patients with steroid-resistant polymyositis.
- Subsequent cases revealed IBM in individuals with various immune-mediated disorders.
Observation:
- A patient with a 30-year diagnosis of limb-girdle muscular dystrophy was found to have inclusion body myositis.
- This case suggests a potential overlap in diagnostic criteria and patient populations.
Findings:
- Inclusion body myositis can present similarly to other myopathies, leading to diagnostic challenges.
- Limb-girdle muscular dystrophy may, in some instances, be a misdiagnosis for inclusion body myositis.
Implications:
- Re-evaluation of long-standing muscular dystrophy diagnoses may be necessary.
- Broader diagnostic awareness of inclusion body myositis is crucial for accurate patient management.
- This finding expands the spectrum of conditions associated with inclusion body myositis.